Stay updated on Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial

Sign up to get notified when there's something new on the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study page now presents a 403 Forbidden error instead of the study record, indicating restricted access to the page. The visible content shows a 403 message and site footer, signaling an access issue rather than updated study information.
    Difference
    18%
    Check dated 2026-09-19T18:54:35.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6, indicating a backend/template update. This change does not modify the study content or the information presented on the page.
    Difference
    0.1%
    Check dated 2026-08-29T20:14:29.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    A site version tag was updated from v3.6.4 to v3.6.5, reflecting a routine platform version update.
    Difference
    0.1%
    Check dated 2026-08-08T15:18:40.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page received a deployment update to revision v3.6.4, replacing the prior v3.6.3. This likely includes minor fixes or refinements to the site’s behavior or layout without altering study content.
    Difference
    0.1%
    Check dated 2026-07-25T08:20:28.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.3, indicating a minor platform update to the page hosting the study record. No study content or results are affected.
    Difference
    0.1%
    Check dated 2026-07-03T22:14:02.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.2, indicating a newer build of the interface. This change does not modify any study details or user-facing interactions.
    Difference
    0.1%
    Check dated 2026-06-26T23:54:37.000Z thumbnail image

Stay in the know with updates to Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of RGX-314 Gene Therapy in Neovascular AMD Clinical Trial page.